Recruitment for Ph.D, M.Pharm, M.Sc to work in Terminal Ballistics Research Laboratory - DRDO | Government of India
Defence Research & Development Organisation (DRDO) works under Department of Defence Research and Development of Ministry of Defence. DRDO dedicatedly working towards enhancing self-reliance in Defence Systems and undertakes design & development leading to production of world class weapon systems and equipment in accordance with the expressed needs and the qualitative requirements laid down by the three services. DRDO is working in various areas of military technology which include aeronautics, armaments, combat vehicles, electronics, instrumentation engineering systems, missiles, materials, naval systems, advanced computing, simulation and life sciences. DRDO while striving to meet the Cutting edge weapons technology requirements provides ample spinoff benefits to the society at large thereby contributing to the nation building.
Post : RESEARCH ASSOCIATE

Yashwantrao Bhonsale College of Pharmacy (YBCP) is the first ever Pharmacy College in Sindhudurg district introducing pinnacle of excellence in pharma education and research. The commitment for total quality management (TQM) and discipline is prime slogan and motto of our college. Shri Achyut Sawantbhonsale, a visionary & dynamic leader had laid the foundation of YBCP at Bhonsale Knowledge City, Charathe, Sawantwadi in 2015. Spread across 16 acres, Bhonsale Knowledge City campus is situated amidst idyllic hills & lush green ambience to increase the harmony between study and nature.
The Rajiv Gandhi Centre for Biotechnology (RGCB) is a growing phenomenon. Located in Thiruvananthapuram, the capital city of Kerala, RGCB began in 1990 amongst humble surroundings as a small charitable society called the Centre for Development of Education, Science and Technology (C-DEST). In 1991, recognizing its potential, the C-DEST was made a “Grant-in-Aid” institute of the Government of Kerala and renamed as Rajiv Gandhi Centre for Development of Education, Science and Technology (RGC-DEST), becoming the first institute in the country to be named after Sri Rajiv Gandhi, the young illustrious and visionary former Prime Minster of India.
ABOUT AUTHORS
At Universal Sompo General Insurance Co. Ltd, we believe relationships with our stakeholders is strengthened & nurtured by imbibing an attitude towards ‘Caring’ and a commitment of ‘Concern’ towards the welfare of our customers and employees during the time of distress, as well as, being preemptive towards mitigating future Risks. Our Customer Outreach activities include organizing Health Camps and Consumer Awareness Roadshows for providing knowledge empowerment and overall wellbeing of our customers. We stand-by our customers and citizens of our country during natural catastrophic events and give our best efforts to try and minimize their distressful situations through our team efforts and leveraging our network channels for extending assistance services. At workplace, we work towards creating a healthy work environment for our fellow colleagues through organizing internal Employee Engagement activities towards Training, Employee Welfare and fun activities during the festive period and important national celebrations. Let us give you a glimpse of our universe.
Clinical Development Services Agency (CDSA) is an extramural unit of Translational Health Science and Technology Institute which is an autonomous institute created by the Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India to strengthen the existing clinical trial / study capacity for affordable health care products in India and raise it to international standards. It is committed to strengthening and expanding the evidence base for healthcare nationally. CDSA has a national reputation for assisting academic investigators, bio-pharma entrepreneurs and innovative SMEs in the delivery of clinical trials and cohort studies throughout their life cycle from set up to closure. Over time, and building on current strengths, the mission of the Clinical Portfolio Section of CDSA is to become a centre of excellence that supports the conduct of Phase III/IV clinical trials and epidemiological studies of national importance.
